The results uncovered (Fig. 2 A) that compared with the normal group, mice in the NAFLD group demonstrated elevated serum levels of AST and ALT, suggesting that HFD caused significant liver injury, while rhein intervention reduced serum ALT and AST levels, with a more pronounced effect observed in the high-dose group. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.